IFN-III is selectively produced by cDC1 and predicts good clinical outcome in breast cancer.
Sci Immunol
; 5(46)2020 04 17.
Article
in En
| MEDLINE
| ID: mdl-32303573
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Dendritic Cells
/
Breast Neoplasms
/
Interferons
Type of study:
Diagnostic_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Female
/
Humans
Language:
En
Journal:
Sci Immunol
Year:
2020
Document type:
Article
Affiliation country:
Francia
Country of publication:
Estados Unidos